Market Overview:
The global Zollinger - Ellison Syndrome testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of Zollinger - Ellison Syndrome, rising demand for accurate and rapid diagnosis, and technological advancements in diagnostic tests. The global Zollinger - Ellison Syndrome testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into synthetic porcine secretin, synthetic human secretin, and Zollinger - Ellison syndrome testin. On the basis of application, the market is segmented into hospital and clinic.
Product Definition:
Zollinger - Ellison Syndrome Testing is a medical procedure used to diagnose Zollinger - Ellison Syndrome, a rare disorder that causes the production of too much stomach acid.
Synthetic Porcine Secretin:
Porcine secretin, also known as zoliporacoidin or zolidinediones is a hormone derived from porcine pancreas. It was first identified in the 1960s and has been used in diagnosis of exocrine pancreatic insufficiency (EPI) since then. The drug is currently off-patent and can be sourced for about USD 6 per gram as pure form with no additives or fillers.
Synthetic Human Secretin:
Synthetic human secretin is a man-made product that is chemically similar to the hormone produced by the body. It is used as a substitute in diagnostic testing for Zollinger - Ellison syndrome, which occurs due to an abnormal function of pancreatic cells.
The test can be performed on blood or urine samples and uses synthetic human secretin (HSeq) as a substrate for enterokinase activity.
Application Insights:
The application segment is bifurcated into hospital and clinic settings. In 2017, the hospital segment dominated the global market with a revenue share of over 80%. The dominance is attributed to factors such as an increase in number of hospitals and rising prevalence of ESS. Moreover, a rise in awareness about zollinger - ellison syndrome has led to an increase in demand for diagnostic tests which has further driven growth.
Clinic-based testing is anticipated to witness lucrative growth during the forecast period owing to factors such as technological advancements that have facilitated ease of use along with cost-effectiveness compared to its counterparts in hospitals.
Regional Analysis:
North America held the largest share in 2016 owing to the presence of a large number of players and well-established healthcare infrastructure. Moreover, an increase in awareness levels among individuals is expected to fuel market growth over the forecast period. Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as increasing prevalence of Zollinger - Ellison syndrome coupled with rising healthcare expenditure and initiatives undertaken by governments for quality medical care facilities at affordable costs. In addition, favorable government policies are also expected to contribute towards regional market development during the same period.
Key participants operating in this industry include but are not limited to: Abbott Laboratories; Actavis plc; Allergan Plc.; Alteogen Inc.; Amgen Inc.; Anika Therapeutics, Inc.; Arthrex, Inc., AUGMENT Medical Solutions LLC; BMS Pharma S.A.
Growth Factors:
- Increasing incidence of Zollinger - Ellison Syndrome (ZES) due to change in lifestyle and dietary habits.
- Growing awareness about the benefits of early diagnosis and treatment of ZES among patients, caregivers, and healthcare professionals.
- Technological advancements in diagnostic tests for ZES that will help improve accuracy and speed of diagnosis.
- Availability of novel therapies for the treatment of ZES that offer better outcomes than existing treatments options.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zollinger - Ellison Syndrome Testing Market Research Report
By Type
Synthetic Porcine Secretin, Synthetic Human Secretin, Zollinger - Ellison Syndrome Testin
By Application
Hospital, Clinic
By Companies
ChiRhoClin, Zollinger - Ellison Syndrome Testin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Zollinger - Ellison Syndrome Testing Market Report Segments:
The global Zollinger - Ellison Syndrome Testing market is segmented on the basis of:
Types
Synthetic Porcine Secretin, Synthetic Human Secretin, Zollinger - Ellison Syndrome Testin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ChiRhoClin
- Zollinger - Ellison Syndrome Testin
Highlights of The Zollinger - Ellison Syndrome Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Synthetic Porcine Secretin
- Synthetic Human Secretin
- Zollinger - Ellison Syndrome Testin
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zollinger - Ellison Syndrome Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zollinger - Ellison Syndrome Testing is a procedure that is used to diagnose the presence of Zollinger - Ellison Syndrome. This syndrome is a disorder that affects the pancreas and can lead to serious health problems. The test involves taking samples of blood from the patient and testing them for signs of the syndrome.
Some of the key players operating in the zollinger - ellison syndrome testing market are ChiRhoClin, Zollinger - Ellison Syndrome Testin.
The zollinger - ellison syndrome testing market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zollinger - Ellison Syndrome Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Zollinger - Ellison Syndrome Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Zollinger - Ellison Syndrome Testing Market - Supply Chain
4.5. Global Zollinger - Ellison Syndrome Testing Market Forecast
4.5.1. Zollinger - Ellison Syndrome Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Zollinger - Ellison Syndrome Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Zollinger - Ellison Syndrome Testing Market Absolute $ Opportunity
5. Global Zollinger - Ellison Syndrome Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Type
5.3.1. Synthetic Porcine Secretin
5.3.2. Synthetic Human Secretin
5.3.3. Zollinger - Ellison Syndrome Testin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Zollinger - Ellison Syndrome Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Zollinger - Ellison Syndrome Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Zollinger - Ellison Syndrome Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Zollinger - Ellison Syndrome Testing Demand Share Forecast, 2019-2026
9. North America Zollinger - Ellison Syndrome Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Type
9.7.1. Synthetic Porcine Secretin
9.7.2. Synthetic Human Secretin
9.7.3. Zollinger - Ellison Syndrome Testin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Zollinger - Ellison Syndrome Testing Demand Share Forecast, 2019-2026
10. Latin America Zollinger - Ellison Syndrome Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Type
10.7.1. Synthetic Porcine Secretin
10.7.2. Synthetic Human Secretin
10.7.3. Zollinger - Ellison Syndrome Testin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Zollinger - Ellison Syndrome Testing Demand Share Forecast, 2019-2026
11. Europe Zollinger - Ellison Syndrome Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Type
11.7.1. Synthetic Porcine Secretin
11.7.2. SyntheticHuman Secretin
11.7.3. Zollinger - Ellison Syndrome Testin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Zollinger - Ellison Syndrome Testing Demand Share, 2019-2026
12. Asia Pacific Zollinger - Ellison Syndrome Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Type
12.7.1. Synthetic Porcine Secretin
12.7.2. Synthetic Human Secretin
12.7.3. Zollinger - Ellison Syndrome Testin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Zollinger - Ellison Syndrome Testing Demand Share, 2019-2026
13. Middle East & Africa Zollinger - Ellison Syndrome Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Zollinger - Ellison Syndrome Testing Market Size and Volume Forecast by Type
13.7.1. Synthetic Porcine Secretin
13.7.2. Synthetic Human Secretin
13.7.3. Zollinger - Ellison Syndrome Testin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Zollinger - Ellison Syndrome Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Zollinger - Ellison Syndrome Testing Market: Market Share Analysis
14.2. Zollinger - Ellison Syndrome Testing Distributors and Customers
14.3. Zollinger - Ellison Syndrome Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ChiRhoClin
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zollinger - Ellison Syndrome Testin
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
